Kong Sun Hold (00295) announced that on August 15, 2024, its wholly-owned subsidiary, Shenzhen Jiangtian Yongjian Technology Co., Ltd., plans to subscribe for 20% of the total equity of Beijing Sibo Huiyi Medical Technology Co., Ltd. at a subscription price of RMB 36 million; and plans to acquire 10% of the total equity of Beijing Sibo Huiyi Medical Technology Co., Ltd. following the subscription, with a total consideration of RMB 14 million from QUBOT Holdings Limited. Therefore, after the subscription and acquisition are completed, the buyer will own 30% of the target company's equity.
The announcement stated that the target company is engaged in the development, production, and commercial development of AI medical robotics and other businesses, and the market prospects of its research and development achievements are promising. The target company's valuation is in line with market financing pricing of similar enterprises. Investing in the target company will help improve the Group's business development in the field of smart healthcare.